bpc-157 for neuropathy Injectable Peptide Healing & Recovery BPC-157 & TB-500 Peptide Therapy

Other studies have demonstrated successful rescue of neurological and electrophysiological deficits in adult Ube3a Stop/p+ mice after reactivation of the Ube3a gene and rescue of neurological defects in adult Mecp2 lox-Stop/y mice after reactivation of the Mecp2 gene [183,184,185]

ODonoghue et al

& Bernier, R

About the study The Phase 2 study (NCT06230523) was a 48-week, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of once-weekly eloralintide monotherapy with placebo in adults with obesity or overweight and at least one weight-related comorbidity and without type 2 diabetes